A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells.

A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells.
复制标题

DOI:
10.3390/genes13122363
复制
发表时间:
2022-12-14
期刊:
影响因子:
3.5
通讯作者:
--
中科院分区:
生物学3区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

多能干细胞(PSC)为探索人类生物学提供了令人兴奋的资源;然而,在包括干细胞在内的许多细胞类型中,基因编辑效率仍然相对较低。使用 CRISPR-Cas9 系统进行基因编辑提供了一种有吸引力的解决方案,该解决方案改进了以前的基因编辑方法;然而,与其他技术一样,脱靶诱变仍然是一个令人担忧的问题。高保真 Cas9 变体极大地减少了脱靶诱变,并为该问题提供了解决方案。为了评估它们作为基于细胞的基因编辑平台的一部分的实用性,使用集成到 AAVS1 安全港基因座的高保真 (HF) 四环素诱导工程化脓性链球菌 SpCas9 (HF-iCas9) 生成了人类 PSC 系。通过对细胞进行工程改造,使其具有 Cas9 的可控表达,我们无需在细胞转染过程中加入大型 Cas9 表达质粒。通过将 DNA 靶向引导 RNA (gRNA) 和供体片段包装到单个质粒主链中,进一步优化了遗传货物的递送。证明了基于同源定向修复 (HDR) 的 CLYBL 安全港位点基因敲入以及内源 SOX2 和 SIX6 基因的潜力。此外,我们使用非同源末端连接(NHEJ)来敲除疾病相关等位基因。这些高保真 CRISPR 工具和由此产生的 HF-iCas9 细胞系将​​有助于跨不同遗传背景的细胞类型报告基因和突变体的生产。
Pluripotent stem cells (PSCs) offer an exciting resource for probing human biology; however, gene-editing efficiency remains relatively low in many cell types, including stem cells. Gene-editing using the CRISPR-Cas9 system offers an attractive solution that improves upon previous gene-editing approaches; however, like other technologies, off-target mutagenesis remains a concern. High-fidelity Cas9 variants greatly reduce off-target mutagenesis and offer a solution to this problem. To evaluate their utility as part of a cell-based gene-editing platform, human PSC lines were generated with a high-fidelity (HF) tetracycline-inducible engineered Streptococcus pyogenes SpCas9 (HF-iCas9) integrated into the AAVS1 safe harbor locus. By engineering cells with controllable expression of Cas9, we eliminated the need to include a large Cas9-expressing plasmid during cell transfection. Delivery of genetic cargo was further optimized by packaging DNA targeting guide RNAs (gRNAs) and donor fragments into a single plasmid backbone. The potential of homology-directed repair (HDR) based gene knock-in at the CLYBL safe harbor site and endogenous SOX2 and SIX6 genes were demonstrated. Moreover, we used non-homologous end-joining (NHEJ) for gene knockout of disease-relevant alleles. These high-fidelity CRISPR tools and the resulting HF-iCas9 cell lines will facilitate the production of cell-type reporters and mutants across different genetic backgrounds.
一个 iCRISPR 平台,用于在人类多能干细胞中进行快速、可多重、可诱导的基因组编辑。
DOI: 10.1016/j.stem.2014.05.018
发表时间: 2014-08-07
期刊: CELL STEM CELL
影响因子: 23.9
作者:
Gonzalez, Federico;Zhu, Zengrong;Shi, Zhong-Dong;Lelli, Katherine;Verma, Nipun;Li, Qing V.;Huangfu, Danwei
通讯作者: Huangfu, Danwei
DOI: 10.1186/s13059-015-0846-3
发表时间: 2015-12-15
期刊: Genome biology
影响因子: 12.3
作者:
Dang Y;Jia G;Choi J;Ma H;Anaya E;Ye C;Shankar P;Wu H
通讯作者: Wu H
DOI: 10.1038/nature13579
发表时间: 2014-09-25
期刊: NATURE
影响因子: 64.8
作者:
Anders, Carolin;Niewoehner, Ole;Duerst, Alessia;Jinek, Martin
通讯作者: Jinek, Martin
DOI: 10.1099/mic.0.27437-0
发表时间: 2005-03-01
期刊: MICROBIOLOGY-SGM
影响因子: 2.8
作者:
Pourcel, C;Salvignol, G;Vergnaud, G
通讯作者: Vergnaud, G
DOI: 10.1126/science.1225829
发表时间: 2012-08-17
期刊: SCIENCE
影响因子: 56.9
作者:
Jinek, Martin;Chylinski, Krzysztof;Charpentier, Emmanuelle
通讯作者: Charpentier, Emmanuelle